Pancytopenia as a rare complication of acute Brucellosis: A case report
DOI:
https://doi.org/10.22122/cdj.v2i1.66Keywords:
Brucellosis, Pancytopenia, Zoonotic Infection, Kurdistan, IranAbstract
Human Brucellosis still challenges many physicians, especially in developing countries where it is still a very common, but sometimes ignored disease. Its reemergence in developed countries and its status as a class B bioterrorist agent has recently attracted much interest. Having over 500,000 new cases annually, Brucellosis is known as one of the most common zoonotic infections in the world and “the great imitator” because of many clinical and hematological manifestations. Brucellosis is still endemic in many developing countries and remains under-diagnosed and sometimes missed reported. Although this province (Kurdistan, Iran) is a Brucella endemic area with a very high prevalence and incidence rate, except for very few and negligible case reports, we did not find any reports or epidemiological study regarding this zoonotic infection. This is the first reported case of Brucellosis with pancytopenia from this western province of Iran which has been neglected. Our case was a 16-year-old girl referred with protracted fever during the last month and undetermined diagnosis. She also suffered from generalized pain, pale skin, sweating, anorexia, and weight loss. After clinical surveying, taking history, and physical examination, Brucella infection was suspected. Diagnosis confirmed by standard tube agglutination test (STA), 1/640. The patient was successfully treated with doxycycline, rifampicin, and ceftriaxone.
References
Madkour MM. Madkour's Brucellosis. 2nd ed. New York, NY: Springer; 2001.
Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005; 352(22): 2325-36.
Moradi GH, Esmaiel Nasab N, Ghaderi E, Sofi Majidpour M, Salimzadeh H. Brucellosis in Kurdistan Province from 1997 to 2003. Annals of Alquds Medicine 2006; 2(1): 32-7.
Godfroid J, Al DS, Pappas G, Roth F, Matope G, Muma J, et al. A "One Health" surveillance and control of brucellosis in developing countries: moving away from improvisation. Comp Immunol Microbiol Infect Dis 2013; 36(3): 241-8.
Pappas G. Treatment of brucellosis. BMJ 2008; 336: 678.
Akhvlediani T, Clark DV, Chubabria G, Zenaishvili O, Hepburn MJ. The changing pattern of human brucellosis: clinical manifestations, epidemiology, and treatment outcomes over three decades in Georgia. BMC Infectious Diseases 2010; 10: 346.
Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 2007; 4(12): e317.
Al-Anazi KA, Al-Jasser AM. Brucella bacteremia in patients with acute leukemia: a case series. J Med Case Rep 2007; 1: 144.
Davis CHE, Troy SB. Brucellosis. N Engl J Med 2005; 353: 1071-2.
Aysha MH, Shayib MA. Pancytopenia and other haematological findings in brucellosis. Scand J Haematol 1986; 36(4): 335-8.
Crosby E, Llosa L, Miro QM, Carrillo C, Gotuzzo E. Hematologic changes in brucellosis. J Infect Dis 1984; 150(3): 419-24.
Eser B, Altuntas F, Soyuer I, Er O, Canoz O, Coskun HS, et al. Acute lymphoblastic leukemia associated with brucellosis in two patients with fever and pancytopenia. Yonsei Med J 2006; 47(5): 741-4.
Doganay M. Editorial (Hot Topic: Human Brucellosis: Update of Bacteriological, Clinical, Diagnostic and Therepeutical Features). Recent Patents on Anti-Infective Drug Discovery 2013; 8(1): 2-3.
Tonna I, Tonna A. Brucellosis. New England Journal of Medicine 2005; 353(10): 1071-2.
Fanni F, Shahbaznejad L, Pourakbari B, Mahmoudi S, Mamishi S. Clinical manifestations, laboratory findings, and therapeutic regimen in hospitalized children with brucellosis in an Iranian Referral Children Medical Centre. J Health Popul Nutr 2013; 31(2): 218-22.
